Press Release 2023 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sabinsa Nanjing Expands into New Facility in Nanjing, China

Clinical Study Published on Sami-Sabinsa’s Shagandha™ Ashwagandha Shows Benefits for Stress Management in Healthy Adults

Sami-Sabinsa Presents Exclusive Round Table Sessions at Food Matters Live Program in the UK

Sami-Sabinsa Group appoints Dr. Vijaya Kumar as new CEO

Sami-Sabinsa To Showcase 35 Years of Category-leading Ingredients, Sustainability Track Record at SupplySide West

Sabinsa Celebrates 35th Anniversary

Certificates

Global Offices

Get in Touch

Disclaimer